Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00345891 · ClinicalTrials.gov registry record · NA

Quit Smoking Program for Lung Cancer Patients' Families (The Family Ties Project)

A NA study of Smoking Cessation, sponsored by Duke University.

Completed
Registry status
NA
Development phase
496
Enrollment target
4
Study locations

NCT00345891: Completed NA study of Smoking Cessation, sponsored by Duke University.

NCT00345891 is a NA study of Smoking Cessation that has completed, run by Duke University. The registered enrollment target is 496 participants, roughly in line with the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target. The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00345891, a NA study of Smoking Cessation, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
496 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to evaluate the impact of delivering a coping-focused intervention as an adjunct to a self-help program to promote smoking cessation among relatives of lung cancer patients.

Conditions Studied

Interventions

  • BEHAVIORAL Coping-focused counseling telephone calls

Study Locations (4)

North Carolina

  • UNC Chapel Hill Multidisciplinary Thoracic Oncology Program - Chapel Hill
  • Durham VAMC Medical Thoracic Oncology Clinic - Durham
  • Duke University Medical Center Thoracic Oncology Program - Durham

Florida

  • H. Lee Moffitt Cancer Center & Research Institute Thoracic Oncology Program - Tampa

Trial Details

FieldValue
Enrollment Target 496 participants
Start Date 2004-06
Est. Completion 2007-12
Phase NA
Duke University

1,725 total trials

What the finished NCT00345891 record still lists

NCT00345891 is an interventional study that assigns participants to a tested intervention. The registered 496 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target.

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Coping-focused counseling telephone calls is the first listed.

NCT00345891 reports a single indexed study location in North Carolina, Florida.

Frequently Asked Questions

What is clinical trial NCT00345891 about?

NCT00345891 is a clinical study titled "Quit Smoking Program for Lung Cancer Patients' Families (The Family Ties Project)". The purpose of this study is to evaluate the impact of delivering a coping-focused intervention as an adjunct to a self-help program to promote smoking cessation among relatives of lung cancer patients.

What is the current status of trial NCT00345891?

This trial is currently completed. It is a NA study. The enrollment target is 496 participants. The study started on 2004-06. Estimated completion is 2007-12.

What conditions does trial NCT00345891 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT00345891?

The interventions under investigation include: Coping-focused counseling telephone calls (BEHAVIORAL).

Who is sponsoring clinical trial NCT00345891?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00345891 being conducted?

This trial has 4 study locations across Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00345891's enrollment target sits among peer trials

496 59th of 188 higher than 130 of 188 other Smoking Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05283720 · 496 participants · Phase 2

    A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

  • NCT06417775 · 496 participants · Phase 3

    Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

  • NCT06778447 · 496 participants · NA

    Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

  • NCT03175224 · 497 participants · Phase 2

    APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00345891, the US trial registry maintained by the National Library of Medicine. NCT00345891 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.